13F-HR filed by Sio Capital Management, LLC
Sio Capital Management, LLC filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-13, with 46 holding rows worth $270,392,199.
- Accession
- 0001214659-23-002122
- Filer
- CIK 1482416
- Filed
- 2023-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 47 entries on the cover page, a total value of $270,392,199 stated on the cover page (in dollars after the unit check, H1), rows summing to $270,392,199 with VALUE read as dollars as filed, 13F file number 028-13691. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 574,200 | $63,162,000 | dollars as filed | put |
| MEDICUS SCIENCES ACQUISITION | G5960S108 | CL A SHS | 2,323,000 | $23,392,610 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 683,425 | $20,229,380 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 52,611 | $17,432,129 | dollars as filed | |
| ORGANON & CO COMMON STOCK | 68622V106 | Stock | 587,836 | $16,418,259 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 54,959 | $15,283,548 | dollars as filed | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 92,000 | $14,392,480 | dollars as filed | put |
| CENCORA INC COM | 03073E105 | Stock | 84,399 | $13,985,758 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 128,000 | $9,948,160 | dollars as filed | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 157,129 | $7,627,042 | dollars as filed | |
| ICON PUB LTD CO SHS | G4705A100 | Stock | 33,983 | $6,601,198 | dollars as filed | |
| INOGEN INC | 45780L104 | COM | 286,692 | $5,650,699 | dollars as filed | |
| AVANTOR INC COM | 05352A100 | Stock | 250,000 | $5,272,500 | dollars as filed | |
| HESKA CORP | 42805E306 | COM | 84,309 | $5,240,647 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 434,635 | $4,741,868 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 340,000 | $3,495,200 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 555,610 | $3,483,675 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 285,000 | $3,206,250 | dollars as filed | |
| Merrimack Pharmaceuticals Inc | 590328209 | Common / Ordinary Stock | 250,000 | $2,865,000 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 67,000 | $2,545,330 | dollars as filed | put |
| HEALTH SCIENCES ACQ CORP 2 | G4411D109 | ORD SHS | 250,000 | $2,495,000 | dollars as filed | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 248,674 | $2,481,767 | dollars as filed | |
| CTI BIOPHARMA CORP | 12648L601 | COM | 330,000 | $1,983,300 | dollars as filed | |
| IVERIC BIO INC | 46583P102 | COM | 86,400 | $1,849,824 | dollars as filed | put |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 1,825,963 | $1,813,181 | dollars as filed | |
| MODULAR MED INC | 60785L207 | COM NEW | 689,352 | $1,378,704 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 87,953 | $1,360,633 | dollars as filed | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 3,004,959 | $1,351,931 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 866,448 | $1,342,994 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 70,000 | $1,271,900 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 152,159 | $1,156,408 | dollars as filed | |
| MOLECULIN BIOTECH INC | 60855D200 | COMMON | 1,036,853 | $1,099,064 | dollars as filed | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 136,325 | $1,007,442 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 235,600 | $822,244 | dollars as filed | put |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 235,500 | $821,895 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 260,448 | $820,411 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 597,678 | $518,665 | dollars as filed | |
| SIENTRA INC | 82621J105 | COM | 2,550,000 | $517,395 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R101 | ADR | 1,270,758 | $457,473 | dollars as filed | |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 359,731 | $341,744 | dollars as filed | |
| NEXTCURE INC | 65343E108 | COM | 130,000 | $183,300 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 43,549 | $118,897 | dollars as filed | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 102,049 | $104,090 | dollars as filed | |
| NYXOAH S A | B6S7WD106 | SHS | 16,110 | $80,389 | dollars as filed | |
| HUMACYTE INC | 44486Q103 | COM | 49,998 | $20,314 | dollars as filed | |
| NEOLEUKIN THERAPEUTICS INC | 64049K104 | COM | 38,312 | $19,501 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-23-002122 | this filing | 2023-02-13 | acceptance time not in the bulk data set |